Cargando…

Probiotics Mediated Modulation of Gut-Flora Might Be a Biotherapeutical Approach for Obesity and Type 2 Diabetes

Detalles Bibliográficos
Autores principales:	Yadav, Hariom, Jain, Shalini, Marotta, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764752/ https://www.ncbi.nlm.nih.gov/pubmed/31565493 http://dx.doi.org/10.4172/2153-0769.1000107e

Ejemplares similares

Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases
por: Kumar, Manoj, et al.
Publicado: (2012)

Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”
por: Kumar, Manoj, et al.
Publicado: (2022)

Colonic flora, Probiotics, Obesity and Diabetes
por: Marik, Paul E.
Publicado: (2012)

A novel probiotics therapy for aging-related leaky gut and inflammation
por: Wang, Shaohua, et al.
Publicado: (2021)

Treating Leaky Syndrome in the Over 65s: Progress and Challenges
por: Jain, Shalini, et al.
Publicado: (2023)

Gut Microbiota: The Next-Gen Frontier in Preventive and Therapeutic Medicine?
por: Nagpal, Ravinder, et al.
Publicado: (2014)

Retraction: Colonic Flora, Probiotics, Obesity and Diabetes
Publicado: (2013)

Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions
por: Ağagündüz, Duygu, et al.
Publicado: (2022)

Significance of African Diets in Biotherapeutic Modulation of the Gut Microbiome
por: Isibor, PO, et al.
Publicado: (2021)

Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet
por: Nagpal, Ravinder, et al.
Publicado: (2018)

Designer Probiotics: The Next-Gen High Efficiency Biotherapeutics
por: Singh, Birbal, et al.
Publicado: (2019)

A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut
por: Mishra, Sidharth P, et al.
Publicado: (2023)

Probiotics and live biotherapeutic products aiming at cancer mitigation and patient recover
por: Schemczssen-Graeff, Zelinda, et al.
Publicado: (2022)

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Novel Biotherapeutics Targeting Biomolecular and Cellular Approaches in Diabetic Wound Healing
por: Singh, Suraj Kumar, et al.
Publicado: (2023)

Development of Microencapsulation Delivery System for Long-Term Preservation of Probiotics as Biotherapeutics Agent
por: Solanki, Himanshu K., et al.
Publicado: (2013)

Gut flora connects obesity with pathological angiogenesis in the eye
por: Scholz, Rebecca, et al.
Publicado: (2016)

Biointerface mineralization generates ultraresistant gut microbes as oral biotherapeutics
por: Geng, Zhongmin, et al.
Publicado: (2023)

Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome
por: Nagpal, Ravinder, et al.
Publicado: (2018)

Promising biotherapeutic prospects of different probiotics and their derived postbiotic metabolites: in-vitro and histopathological investigation
por: El Far, Mona S., et al.
Publicado: (2023)

Unique Gut Microbiome Signatures Depict Diet-Versus Genetically Induced Obesity in Mice
por: Nagpal, Ravinder, et al.
Publicado: (2020)

A Keystone Gut Bacterium Christensenella minuta—A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases
por: Ang, Wei-Shan, et al.
Publicado: (2023)

Gut microbiota: next frontier in understanding human health and development of biotherapeutics
por: Prakash, Satya, et al.
Publicado: (2011)

Potentials and limitations of microorganisms as renal failure biotherapeutics
por: Jain, Poonam, et al.
Publicado: (2009)

Gut microbiome and aging: Physiological and mechanistic insights
por: Nagpal, Ravinder, et al.
Publicado: (2018)

Pretreatment with probiotic Bifico ameliorates colitis‐associated cancer in mice: Transcriptome and gut flora profiling
por: Song, Huan, et al.
Publicado: (2018)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

Integrated BioTherapeutics
por: Aman, M. Javad
Publicado: (2018)

Tibetan tea reduces obesity brought on by a high‐fat diet and modulates gut flora in mice
por: He, Gang, et al.
Publicado: (2023)

Diet-microbiome-gut-brain nexus in acute and chronic brain injury
por: Krakovski, Maria Alexander, et al.
Publicado: (2022)

HEAT KILLED LB. PARACASEI OR CELL WALL LIPOTEICHOIC ACID AMELIORATES AGE-RELATED LEAKY GUT AND INFLAMMATION
por: Wang, Shaohua, et al.
Publicado: (2019)

A clinical study on Virechana Karma (therapeutic purgation) over the gut flora with special reference to obesity
por: Chaturvedi, Ashutosh, et al.
Publicado: (2019)

Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria
por: Cuffaro, Bernardo, et al.
Publicado: (2021)

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023)

Systematic Analysis of the Association between Gut Flora and Obesity through High-Throughput Sequencing and Bioinformatics Approaches
por: Chiu, Chih-Min, et al.
Publicado: (2014)

Editorial: Impact of ketogenic diet on metabolic and brain health
por: Sacchetti, Paola, et al.
Publicado: (2023)

Microbiome in aging of Gut and Brain (MiaGB): paving the ways to understand gut-brain axis in aging
por: Masternak, Michal M., et al.
Publicado: (2022)

Exploiting Prophage-Mediated Lysis for Biotherapeutic Release by Lactobacillus reuteri
por: Alexander, Laura M., et al.
Publicado: (2019)

Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora
por: Chuang, Li-Chuan, et al.
Publicado: (2010)

In vivo selection of novel biotherapeutics
por: Ruozi, Giulia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_285qqraq2p5bj0n3d19oketjji